Literature DB >> 8963679

Loss of A1 adenosine receptors in human temporal lobe epilepsy.

M Glass1, R L Faull, J Y Bullock, K Jansen, E W Mee, E B Walker, B J Synek, M Dragunow.   

Abstract

Using quantitative receptor autoradiographic methods we have examined A1 adenosine receptors, adenosine uptake sites, benzodiazepine receptors, NMDA, AMPA, and kainic acid receptors in temporal lobes removed from patients suffering from complex partial seizures and in normal control post-mortem temporal cortex. Binding to A1 adenosine receptors and NMDA receptors was reduced in epileptic temporal cortex, while the other neurochemical parameters were unchanged. The reason for this A1 receptor loss is unclear as it occurred in both idiopathic and symptomatic cases and thus may be a consequence rather than an initial cause of seizures. However, because adenosine is a powerful anticonvulsant substance, loss of anticonvulsant A1 receptors may contribute to the human epileptic condition. It is also possible that the observed differences in A1 binding are due to autopsy vs. biopsy changes in the levels of A1 adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963679     DOI: 10.1016/0006-8993(95)01313-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

2.  Adenosine: a fundamental factor formed from Fatty feasts for fighting fits?

Authors:  Jong M Rho
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

3.  Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?

Authors:  Tianfu Li; Nikki Lytle; Jing-Quan Lan; Ursula S Sandau; Detlev Boison
Journal:  Glia       Date:  2011-09-30       Impact factor: 7.452

4.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

Review 5.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

6.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

7.  GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy.

Authors:  A Billinton; V H Baird; M Thom; J S Duncan; N Upton; N G Bowery
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 8.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

9.  Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Isao Matsuoka; Jesús A García-Sevilla
Journal:  Purinergic Signal       Date:  2018-02-28       Impact factor: 3.765

10.  Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE).

Authors:  Aurora R Barros-Barbosa; Fátima Ferreirinha; Ângela Oliveira; Marina Mendes; M Graça Lobo; Agostinho Santos; Rui Rangel; Julie Pelletier; Jean Sévigny; J Miguel Cordeiro; Paulo Correia-de-Sá
Journal:  Purinergic Signal       Date:  2016-09-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.